Welcome to our dedicated page for Intuitive Surgical SEC filings (Ticker: ISRG), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Intuitive Surgical’s disclosures run deep—hundreds of pages on da Vinci procedure volumes, FDA clearances, and patent litigation that can shift margins overnight. Finding the revenue split between system sales and high-margin instruments or spotting safety-related 8-K material events explained can consume hours. That’s the problem our platform solves.
Stock Titan delivers AI-powered summaries that turn Intuitive Surgical annual report 10-K simplified narratives into plain language and flag the exact tables analysts search for—installed base counts, per-procedure revenue, and R&D spend. Need the latest Intuitive Surgical quarterly earnings report 10-Q filing or Intuitive Surgical earnings report filing analysis? We post real-time links the moment they hit EDGAR and attach concise breakdowns of segment trends. Our engine also monitors Intuitive Surgical Form 4 insider transactions real-time, highlighting unusual executive stock transactions Form 4 within minutes, so you never miss a signal.
Whether you’re understanding Intuitive Surgical SEC documents with AI for long-term valuation or tracking Intuitive Surgical insider trading Form 4 transactions ahead of market moves, every filing type is covered. Quickly parse Intuitive Surgical proxy statement executive compensation details, review Intuitive Surgical 8-K material events explained after product recalls, and compare guidance changes across quarters. All SEC filings explained simply—so you focus on decisions, not document hunts.
Insider transactions by Gary S. Guthart, Executive Chair of Intuitive Surgical (ISRG). On 08/29/2025 Mr. Guthart acquired 36,000 shares via exercise of a non-qualified stock option at an exercise price of $79.6378 and sold 29,360 shares at a weighted average price of $472.4873 under a pre-existing Rule 10b5-1 trading plan that expires April 28, 2026. After these transactions he directly beneficially owned 49,187 shares and holds additional indirect ownership through family trusts totaling 1,241,843 shares combined. The option vests partly six months after grant with further monthly vesting and expires 02/15/2027. The Form 4 was signed on 09/02/2025.
Form 144 filing for Intuitive Surgical, Inc. (ISRG) shows a proposed sale of 29,360 common shares to be executed through Morgan Stanley Smith Barney on 08/29/2025, with an aggregate market value of $13,872,227.13. The shares were acquired the same day by stock option exercise and paid for in cash. The filing identifies prior sales during the past three months by Gary S. Guthart totaling 10,693 shares on 07/28/2025 for gross proceeds of $5,329,417.02. The filer affirms they are not aware of any undisclosed material adverse information and includes the standard Rule 10b5-1/trading-plan notice language.
Form 4 details insider activity at Intuitive Surgical (ISRG) on 28 Jul 2025 by Executive Chair Gary S. Guthart:
- Option exercise: 7,893 non-qualified options exercised at $59.4622.
- Open-market sales: Same 7,893 shares sold at a weighted-avg $498.64 (~$3.9 m). Two family trusts each sold 1,400 shares at ~$495, adding ≈$1.4 m.
- Charitable gift: 10,500 shares transferred to a Donor-Advised Fund (price reported $0).
After the transactions Guthart holds 13,187 shares directly and ~1.24 m shares indirectly through trusts, maintaining a large economic stake. All trades were executed under a Rule 10b5-1 plan expiring 28 Apr 2026, suggesting pre-scheduled diversification rather than a sudden sentiment shift.
Intuitive Surgical, Inc. (ISRG) – Form 144 filing: an unidentified insider has notified the SEC of a planned sale of 5,600 common shares through broker Charles Schwab. The shares were acquired via stock-option exercise on 12-03-2018. Proposed sale date is 28-Jul-2025.
The filing lists an aggregate market value of US$2.77 million, implying a price of roughly US$495 per share. Relative to the company’s 358.48 million shares outstanding, the disposition represents only about 0.0016 %, so it is immaterial to the public float. No prior sales were reported for the past three months and no Rule 10b5-1 trading plan date is supplied.
Form 144 indicates intent rather than completion; actual execution will depend on market conditions and the insider’s discretion. While insider selling can sometimes be viewed cautiously by investors, the small size versus total shares and lack of accompanying negative disclosures suggest limited market impact.
Intuitive Surgical (ISRG) EVP & Chief Medical Officer Myriam Curet filed a Form 4 for transactions dated 07/25/2025.
- Option exercise: 4,500 non-qualified options exercised at $242.3367 under the 2010 Incentive Award Plan.
- Share sale: The 4,500 resulting shares were immediately sold at $492.48, generating gross proceeds of roughly $2.2 million.
- Ownership: After both trades, Curet directly holds 353 common shares; net beneficial ownership is unchanged.
- Derivative position: 5,030 options remain outstanding.
- Transactions were executed under a Rule 10b5-1 trading plan that expires 13 Aug 2025.
The filing is routine, disclosing compliance with Section 16 insider-trading rules and does not alter control or capital structure.
FAQ
What is the current stock price of Intuitive Surgical (ISRG)?
What is the market cap of Intuitive Surgical (ISRG)?
